Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HNSBF - Sarepta Therapeutics inks deal for imlifidase for use in muscular dystrophies

HNSBF - Sarepta Therapeutics inks deal for imlifidase for use in muscular dystrophies

Hansa Biopharma AB
  • Sarepta Therapeutics (NASDAQ:SRPT) signs an agreement with Hansa Biopharma (OTC:HNSBF) for imlifidase, for rare Immunoglobulin G (IgG) mediated diseases.
  • More news on: Sarepta Therapeutics, Inc., Hansa Biopharma AB (publ), Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Hansa Biopharma AB
Stock Symbol: HNSBF
Market: OTC
Menu
HNSBF HNSBF Quote HNSBF Short HNSBF News HNSBF Articles HNSBF Message Board
Get HNSBF Alerts

News, Short Squeeze, Breakout and More Instantly...